| Financial Year |
March 31 2023 |
| Monetary Funds |
345,612,550.01 |
| Held-for-trading Financial Assets |
1,594,000.00 |
| Notes Receivable |
1,148,200.81 |
| Accounts Receivable |
292,246,025.30 |
| Advances to Suppliers |
104,328,884.39 |
| Other Receivables |
5,308,227.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
891,176,332.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
563,719,564.97 |
| Other Current Assets |
93,815,492.64 |
| Total Current Assets |
2,304,686,018.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
422,163,324.72 |
| Long-term Equity Investment |
391,362,626.08 |
| Investment Properties |
1,652,430,669.99 |
| Fixed Assetes |
1,161,673,207.16 |
| Under-construction Projects |
74,988,354.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
296,406,013.31 |
| R&D expenses |
-- |
| Goodwill |
14,428,555.49 |
| Long-Term Deferred and Prepaid Expenses |
32,772,723.41 |
| Deferred Income Tax Assets |
54,471,856.25 |
| Other Non-Current Assets |
119,474,237.62 |
| Sub-Total of Non-Current Assets |
4,224,072,872.64 |
| Total Assets |
6,528,758,890.68 |
| Short-Term Loans |
603,705,552.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
109,965,705.06 |
| Accounts Payable |
353,136,189.82 |
| Accounts Received In Advance |
4,731,703.39 |
| Employee Compensation Payable |
42,559,350.04 |
| Taxes Payable |
21,298,242.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
59,822,042.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
845,807,855.78 |
| Other Current Liabilities |
22,257,221.37 |
| Sub-Total of Current Liabilities |
2,235,843,568.04 |
| Long-term Loans |
1,217,364,705.72 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
90,423,828.99 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
121,910,989.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,475,253,417.79 |
| Total Liabilities |
3,711,096,985.83 |
| Paid-In Capital(Or Share Stock) |
423,387,356.00 |
| Capital Surplus |
2,263,041,494.08 |
| Surplus Reserve |
156,335,056.74 |
| LESS:Treasury Stock |
50,102,995.06 |
| Undistributed Profits |
-193,082,479.69 |
| Minority Stockholder's Interest |
197,488,369.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,620,173,535.81 |
| Owner's Equity（Stockholder's Equity） |
2,817,661,904.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,528,758,890.68 |
